Cibc Private Wealth Group, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 43 shares of RARE stock, worth $1,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43Holding current value
$1,533% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$200 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$148 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$115 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$93.4 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.5B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...